Several studies have implicated TGF-β signaling in progression to androgen independence in prostate cancer, dysregulated TGF-β signaling via dominant negative TGF-β type II receptor (DNTGF-βRII) in animal models of prostate cancer exhibit greater proliferation and reduced apoptosis following ADT. Here, TGFB1 is linked to Familial prostate cancer.